NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NGNE NEUROGENE INC

未开盘 11-22 16:00:00 EST

20.30

+4.71

+30.21%

盘后20.70

+0.40+1.97%

19:29 EST

最高20.93	最低15.48	成交量106.29万
今开15.48	昨收15.59	日振幅34.96%
总市值3.02亿	流通市值1.34亿	总股本1,485万
成交额2,013万	换手率16.04%	流通股本662.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":20.3,"timestamp":1732309200000,"preClose":15.59,"halted":0,"volume":1062923,"hourTrading":{"tag":"盘后","latestPrice":20.7,"preClose":20.3,"latestTime":"19:29 EST","volume":5873,"amount":119601.3413,"timestamp":1732321767359},"delay":0,"floatShares":6625300,"shares":14854700,"eps":-0.255445,"marketStatus":"未开盘","marketStatusCode":0,"change":4.71,"latestTime":"11-22 16:00:00 EST","open":15.48,"high":20.93,"low":15.48,"amount":20126785.014514,"amplitude":0.349583,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.255445,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1394168400000,"adjPreClose":15.59,"preHourTrading":{"tag":"盘前","latestPrice":15.4683,"preClose":15.59,"latestTime":"09:26 EST","volume":1781,"amount":26973.378575,"timestamp":1732285585697},"postHourTrading":{"tag":"盘后","latestPrice":20.7,"preClose":20.3,"latestTime":"19:29 EST","volume":5873,"amount":119601.3413,"timestamp":1732321767359},"volumeRatio":1.0874014951775561,"impliedVol":0.9865,"impliedVolPercentile":0.6667},"requestUrl":"/m/hq/s/NGNE","defaultTab":"news","newsList":[{"id":"2485009442","title":"Neurogene Inc.2024财年第三财季实现净利润-20.22百万美元，同比减少346.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485009442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485009442?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377634,"startTime":"0","endTime":"0","summary":"11月24日，Neurogene Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.22百万美元，同比减少346.36%；其中营业收入为0.00美元，每股基本收益为-1.19美元。从资产负债表来看，Neurogene Inc.总负债26.71百万美元，其中短期债务2.91百万美元，资产负债比为0.07，流动比率为0.10。机构评级：截至2024年11月24日，当前有5家机构对Neurogene Inc.目标价做出预测，其中目标均价为52.80美元，其中最低目标价为45.00美元，最高目标价为72.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000108a25045b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000108a25045b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NGNE"],"gpt_icon":0},{"id":"2485267669","title":"Neurogene Inc.盘中异动 早盘快速上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267669?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:22","pubTimestamp":1732288971,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时22分，Neurogene Inc.股票出现波动，股价快速上涨6.03%。截至发稿，该股报16.53美元/股，成交量7.1461万股，换手率0.48%，振幅5.64%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1581.77%、111.06%、81.86%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.96%、45.86%、38.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232251abd7a8d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232251abd7a8d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRPX","NGNE","BK4139"],"gpt_icon":0},{"id":"2484567933","title":"Neurogene 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2484567933","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484567933?lang=zh_cn&edition=full","pubTime":"2024-11-19 07:08","pubTimestamp":1731971293,"startTime":"0","endTime":"0","summary":"   * Neurogene Inc   报告，截至9月30日的季度调整后每股亏损1.19美元，高于去年同期的每股亏损1.64美元。六位分析师对该季度的平均预期为每股亏损 1.22 美元。华尔街预期为每股亏损 1.34 美元至-89 美分。* Neurogene Inc 公布的季度每股收益为亏损 1.19 美元。* 该公司当季亏损 2022 万美元。* Neurogene Inc 本季度股价下跌了 17.7%，今年迄今为止上涨了 78.1%。华尔街对 Neurogene Inc 的 12 个月目标价中位数为 60.00 美元。本摘要由 LSEG 11 月 18 日 11:07 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Neurogene 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2484567626","title":"Neurogene Inc.股价重挫35.56% 市值跌1.03亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484567626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484567626?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940261,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Neurogene Inc.股票出现异动，股价快速跳水35.56%。截至发稿，该股报22.24美元/股，成交量8.7907万股，换手率0.68%，振幅4.49%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为514.42%、179.03%、174.93%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Innate Pharma、Regenxbio Inc.，振幅分别为11.85%、10.42%、7.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822310198e43398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822310198e43398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2484462107","title":"BUZZ-神经基因公司因严重副作用暂停部分基因治疗研究后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2484462107","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484462107?lang=zh_cn&edition=full","pubTime":"2024-11-18 20:46","pubTimestamp":1731933994,"startTime":"0","endTime":"0","summary":"BUZZ-神经基因公司因严重副作用暂停部分基因治疗研究后业绩下滑11月18日 - ** 药物开发商NeurogeneNGNE.O股价盘前下跌19%至28美元 ** 该公司称，在报告一名参与者出现与治疗相关的严重副作用后，已暂停测试其实验性基因疗法的大剂量版本 ** Neurogene公司称，该参与者因高炎症综合征而处于危急状态。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP0VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2483041088","title":"Neurogene Inc.盘中异动 早盘大幅上涨6.43%报42.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483041088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483041088?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594677,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Neurogene Inc.股票出现波动，股价大幅拉升6.43%。截至发稿，该股报42.21美元/股，成交量2223股，换手率0.02%，振幅0.25%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1414.78%、19.66%、11.31%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc.、Pulmatrix, Inc.，振幅分别为25.00%、15.53%、14.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223117abc1599a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223117abc1599a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4183","NGNE","ELAB"],"gpt_icon":0},{"id":"2482742660","title":"美股异动 | 公布Rett综合症基因治疗试验数据后，Neurogene(NGNE.US)盘后暴跌35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482742660","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482742660?lang=zh_cn&edition=full","pubTime":"2024-11-12 14:31","pubTimestamp":1731393061,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Neurogene在周一盘后一度暴跌56%，截至发稿，该股大跌35%，报46.14美元。消息面上，该公司公布了针对儿科患者进行NGN-401的中期1/2期数据。此外，这四名患者在Rett综合征行为问卷中的得分也有所改善，较基线提高了28%-52%。Neurogene还表示，他们已经启动了一项青少年/成人队列研究，以观察NGN-401是否能治疗更广泛的人群。Taysha Gene Therapies正在开发一种与之竞争的Rett综合征基因疗法TSHA-102，该公司股价在盘后交易中一度上涨了约35%，截止发稿，上涨了12.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2482676619","title":"BUZZ-Neurogene公司不再进行巴顿氏病基因治疗；股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2482676619","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482676619?lang=zh_cn&edition=full","pubTime":"2024-11-12 05:31","pubTimestamp":1731360672,"startTime":"0","endTime":"0","summary":"    11月11日 - ** 疗法开发商Neurogene  股价盘后下跌46.9%至37.99美元** 该公司称，预计 ，不会继续推进其巴顿氏病基因疗法的开发。** 公司表示，目前正在评估开发项目的选择方案** 巴顿氏病是一种影响神经系统的罕见遗传性致命疾病** 截至上日收盘，股价年累计涨幅超过一倍","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2480581607","title":"Neurogene Inc.股价拉升20.40% 市值涨1.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581607?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Neurogene Inc.股票出现异动，股价快速拉升20.40%。截至发稿，该股报55.47美元/股，成交量1.5809万股，换手率0.12%，振幅2.54%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为231.37%、123.83%、40.42%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Cns Pharmaceuticals, Inc.，振幅分别为29.83%、11.39%、7.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422312595bdc99f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422312595bdc99f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2478487328","title":"Neurogene Inc.盘中异动 急速上涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478487328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478487328?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:33","pubTimestamp":1730122421,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时33分，Neurogene Inc.股票出现异动，股价急速上涨5.83%。截至发稿，该股报51.19美元/股，成交量1248股，换手率0.01%，振幅0.00%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Revance Therapeutics, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为544.82%、48.22%、36.71%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Humacyte Inc C/Wts 27/08/2026 、Creative Medical Technology Holdings, Inc.，振幅分别为34.60%、15.73%、14.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821334298e3ecf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821334298e3ecf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2478339099","title":"Neurogene Inc.盘中异动 早盘快速上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478339099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478339099?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:36","pubTimestamp":1729863418,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时36分，Neurogene Inc.股票出现异动，股价快速上涨5.50%。截至发稿，该股报50.85美元/股，成交量1435股，换手率0.01%，振幅3.01%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Monopar Therapeutics Inc.较为活跃，换手率分别为484.99%、405.68%、27.17%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.、180 Life Sciences Corp.，振幅分别为77.79%、40.89%、32.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213659ab73f48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213659ab73f48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB","BK4139","NGNE"],"gpt_icon":0},{"id":"2477355971","title":"Neurogene Inc.盘中异动 大幅下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477355971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477355971?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:29","pubTimestamp":1729607349,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时29分，Neurogene Inc.股票出现波动，股价急速跳水5.24%。截至发稿，该股报49.90美元/股，成交量8446股，换手率0.07%，振幅3.67%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4044.81%、3063.61%、1887.83%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为140.78%、99.41%、80.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222909ab6c40d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222909ab6c40d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2472968249","title":"Neurogene Inc.盘中异动 早盘快速上涨5.73%报46.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472968249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472968249?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:05","pubTimestamp":1728050717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时05分，Neurogene Inc.股票出现波动，股价大幅拉升5.73%。截至发稿，该股报46.96美元/股，成交量2.0709万股，换手率0.16%，振幅5.08%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为11990.33%、41.55%、31.01%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Sagimet Biosciences Inc. - Series A，振幅分别为47.42%、40.36%、24.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004220518ab67bd9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004220518ab67bd9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2472356542","title":"Neurogene Inc.盘中异动 股价大涨6.62%报43.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356542?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:27","pubTimestamp":1727724435,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时27分，Neurogene Inc.股票出现异动，股价快速上涨6.62%。截至发稿，该股报43.00美元/股，成交量8.1503万股，换手率0.63%，振幅7.20%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Capricor Therapeutics, Inc.、Briacell Therapeutics Corp.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为235.26%、66.78%、62.21%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Capricor Therapeutics, Inc.，振幅分别为87.30%、85.25%、56.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100103271598e39e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100103271598e39e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2470653632","title":"Neurogene Inc.盘中异动 早盘股价大涨5.31%报42.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470653632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470653632?lang=zh_cn&edition=full","pubTime":"2024-09-25 22:19","pubTimestamp":1727273945,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日22时19分，Neurogene Inc.股票出现异动，股价急速拉升5.31%。截至发稿，该股报42.84美元/股，成交量9912股，换手率0.08%，振幅4.41%。Neurogene Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大，Seelos Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为252.96%、168.40%、79.85%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cero Therapeutics Holdings, Inc.、Orgenesis Inc.，振幅分别为107.20%、73.43%、32.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252219069719c9e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409252219069719c9e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2468508622","title":"Neurogene Inc.盘中异动 早盘急速拉升6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508622?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:02","pubTimestamp":1726754557,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时02分，Neurogene Inc.股票出现波动，股价急速拉升6.17%。截至发稿，该股报43.85美元/股，成交量8979股，换手率0.07%，振幅3.16%。Neurogene Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为2547.47%、534.14%、125.41%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为81.66%、76.38%、52.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220237ab64a42c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220237ab64a42c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2457858994","title":"Neurogene Inc    预计每股亏损 1.05 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457858994","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457858994?lang=zh_cn&edition=full","pubTime":"2024-08-07 10:55","pubTimestamp":1722999345,"startTime":"0","endTime":"0","summary":"   * Neurogene Inc    预计将于8月8日公布截至2024年6月30日的财报(预计)    *    * LSEG的分析师平均预计Neurogene Inc每股亏损1.05美元。* 华尔街对 Neurogene Inc 的 12 个月目标价中位数为 51.00 美元，高于其上次收盘价 37.87 美元。8月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Neurogene Inc    预计每股亏损 1.05 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2442357523","title":"Neurogene(NGNE.US)获Baird首次覆盖给予优于大市评级, 目标价54.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2442357523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442357523?lang=zh_cn&edition=full","pubTime":"2024-06-11 17:20","pubTimestamp":1718097644,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2440834912","title":"HC Wainwright &amp; Co.：重申Neurogene(NGNE.US)评级，由买入调整至买入评级, 目标价由51.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440834912","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440834912?lang=zh_cn&edition=full","pubTime":"2024-06-04 18:37","pubTimestamp":1717497467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","NGNE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurogene.com","stockEarnings":[{"period":"1week","weight":-0.4118},{"period":"1month","weight":-0.5819},{"period":"3month","weight":-0.419},{"period":"6month","weight":-0.3678},{"period":"1year","weight":0.4625},{"period":"ytd","weight":0.0475}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neurogene Inc.前身为6175813加拿大公司（6175813 Canada Inc.）。该公司根据加拿大商业公司法，于2003年12月26日注册成立。Neurogene的使命是治疗毁灭性的神经系统疾病，以改善受这些罕见疾病影响的患者和家庭的生活。Neurogene正在开发新的方法和治疗方法，以解决传统基因疗法在中枢神经系统疾病中的局限性。这包括选择一种递送方法以最大限度地分配到目标组织，并设计产品以最大限度地提高效力和纯度，以实现优化的功效和安全性。Neurogene的新型专有EXACT转基因调控平台技术允许传递治疗水平，同时限制与常规基因治疗相关的转基因毒性。Neurogene在德克萨斯州休斯顿建造了一座最先进的基因疗法制造设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.087633},{"month":2,"riseRate":0.3,"avgChangeRate":-0.066901},{"month":3,"riseRate":0.5,"avgChangeRate":0.07464},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.109442},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.011201},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.067793},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.101505},{"month":8,"riseRate":0.909091,"avgChangeRate":0.860852},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.065613},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.066641},{"month":11,"riseRate":0.454545,"avgChangeRate":0.024404},{"month":12,"riseRate":0.7,"avgChangeRate":0.189368}],"exchange":"NASDAQ","name":"NEUROGENE INC","nameEN":"NEUROGENE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NEUROGENE INC,NGNE,NEUROGENE INC股票,NEUROGENE INC股票老虎,NEUROGENE INC股票老虎国际,NEUROGENE INC行情,NEUROGENE INC股票行情,NEUROGENE INC股价,NEUROGENE INC股市,NEUROGENE INC股票价格,NEUROGENE INC股票交易,NEUROGENE INC股票购买,NEUROGENE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}